DYN

Dyne Therapeutics, Inc.

DYN · CIK 1818794 · Annual (10-K) · Last 6 years

Financial Trends

Revenue
20202025
Net Income−$446M
20202025
Operating CF−$403M
20202025
Free Cash Flow−$405M
20202025

Income Statement

MetricFY 2025↕FY 2024↕FY 2023↕FY 2022↕FY 2021↕FY 2020↕
Revenue——————
Cost of Revenue——————
Gross Profit——————
R&D Expense$0.4B$0.3B$0.2B$0.1B$0.1B$0.0B
SG&A Expense——————
Operating Income$-0.5B$-0.3B$-0.2B$-0.2B$-0.2B$-0.1B
Net Income$-0.4B$-0.3B$-0.2B$-0.2B$-0.1B$-0.1B
EPS (Basic)$-3.47$-3.37$-3.95$-3.23——
EPS (Diluted)$-3.47$-3.37$-3.95$-3.23——

Balance Sheet

MetricFY 2025↕FY 2024↕FY 2023↕FY 2022↕FY 2021↕FY 2020↕
Total Assets$1.2B$0.7B$0.2B$0.3B$0.4B$0.4B
Current Assets$1.1B$0.7B$0.1B$0.3B$0.4B$0.3B
Cash & Equivalents$0.9B$0.4B$0.1B$0.2B$0.2B$0.3B
Total Liabilities$0.2B$0.1B$0.1B$0.1B$0.1B$0.0B
Current Liabilities$0.1B$0.0B$0.1B$0.0B$0.0B$0.0B
Stockholders' Equity$1.0B$0.6B$0.1B$0.3B$0.4B$0.3B

Cash Flow Statement

MetricFY 2025↕FY 2024↕FY 2023↕FY 2022↕FY 2021↕FY 2020↕
Operating Cash Flow$-0.4B$-0.3B$-0.2B$-0.2B$-0.1B$-0.0B
Investing Cash Flow$-0.0B$-0.2B$0.1B$0.1B$-0.1B$-0.0B
Capital Expenditures$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B
Financing Cash Flow$0.9B$0.8B$0.1B$0.0B$0.2B$0.4B
← Companies